Japan
· Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 373.54 billion. The enterprise value is 382.97 billion.
| Market Cap | 373.54B |
| Enterprise Value | 382.97B |
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Organo has 46.00 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 46.00M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 26.31% |
| Float | 25.50M |
Valuation Ratios
The trailing PE ratio is 18.75 and the forward PE ratio is 17.93.
| PE Ratio | 18.75 |
| Forward PE | 17.93 |
| PS Ratio | 2.34 |
| PB Ratio | 3.45 |
| P/TBV Ratio | 3.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.24 |
| EV / Sales | 2.41 |
| EV / EBITDA | 13.55 |
| EV / EBIT | 14.54 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.33 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | n/a |
| Interest Coverage | 100.27 |
Financial Efficiency
Return on equity (ROE) is 19.93% and return on invested capital (ROIC) is 12.56%.
| Return on Equity (ROE) | 19.93% |
| Return on Assets (ROA) | 9.31% |
| Return on Capital (ROIC) | 12.56% |
| Revenue Per Employee | 63.38M |
| Profits Per Employee | 7.92M |
| Employee Count | 2,512 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 6.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +46.44% |
| 50-Day Moving Average | 8,150.20 |
| 200-Day Moving Average | 7,624.10 |
| Relative Strength Index (RSI) | 42.78 |
| Average Volume (20 Days) | 251,460 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 159.21 billion and earned 19.91 billion in profits. Earnings per share was 433.18.
| Revenue | 159.21B |
| Gross Profit | 48.86B |
| Operating Income | 26.17B |
| Pretax Income | 27.77B |
| Net Income | 19.91B |
| EBITDA | 28.10B |
| EBIT | 26.17B |
| Earnings Per Share (EPS) | 433.18 |
Balance Sheet
The company has 16.67 billion in cash and 25.85 billion in debt, giving a net cash position of -9.18 billion or -199.64 per share.
| Cash & Cash Equivalents | 16.67B |
| Total Debt | 25.85B |
| Net Cash | -9.18B |
| Net Cash Per Share | -199.64 |
| Equity (Book Value) | 108.49B |
| Book Value Per Share | 2,353.03 |
| Working Capital | 86.39B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.69%, with operating and profit margins of 16.44% and 12.50%.
| Gross Margin | 30.69% |
| Operating Margin | 16.44% |
| Pretax Margin | 17.44% |
| Profit Margin | 12.50% |
| EBITDA Margin | 17.65% |
| EBIT Margin | 16.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 142.00, which amounts to a dividend yield of 1.75%.
| Dividend Per Share | 142.00 |
| Dividend Yield | 1.75% |
| Dividend Growth (YoY) | 78.38% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.12% |
| Shareholder Yield | 1.62% |
| Earnings Yield | 5.33% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 5.17.
| Altman Z-Score | 5.17 |
| Piotroski F-Score | n/a |